
SARS-CoV 2 Infection (Covid-19) and Cardiovascular Disease in Africa: Health Care and Socio-Economic Implications
References
- Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, et al. Clinical features and short-term outcomes of 221 patients with Covid-19 in Wuhan, China. J Clin Virol. 2020; 127. 104364. DOI: 10.1016/j.jcv.2020.104364.
- Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of Covid-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020. DOI: 10.1016/j.annonc.2020.03.296.
- Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. Covid-19 and cardiovascular disease: From basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020; 17(9): 543–58. DOI: 10.1038/s41569-020-0413-9.
- Clark A, Jit M, Warren-Gash C, Guthrie B, Wang HHX, Mercer SW, et al. Global, regional, and national estimates of the population at increased risk of severe Covid-19 due to underlying health conditions in 2020: A modelling study. Lancet Glob Health. 2020; 8(8): e1003–e17. DOI: 10.1016/S2214-109X(20)30264-3.
- Keates AK, Mocumbi AO, Ntsekhe M, Sliwa K, Stewart S. Cardiovascular disease in Africa: Epidemiological profile and challenges. Nature Reviews Cardiology. 2017; 14(5): 273. DOI: 10.1038/nrcardio.2017.19
- Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England Journal of Medicine. 2020.
- Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. Covid-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research. 2020. DOI: 10.1016/j.jare.2020.03.005
- Ziebuhr J. Molecular biology of severe acute respiratory syndrome coronavirus. Current Opinion in Microbiology. 2004; 7(4): 412–9. DOI: 10.1016/j.mib.2004.06.007
- Duan S, Zhao X, Wen R, Huang J-J, Pi G, Zhang S, et al. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomedical and environmental sciences: BES. 2003; 16(3): 246–55.
- Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following Covid-19 infection. The Lancet Infectious Diseases. 2020. DOI: 10.1016/S1473-3099(20)30195-X
- Han Y, Yang H. The transmission and diagnosis of 2019 novel coronavirus infection disease (Covid-19): A Chinese perspective. Journal of Medical Virology. 2020; 92(6): 639–44. DOI: 10.1002/jmv.25749
- Van Doremalen N, Bushmaker T, Morris D, Holbrook M, Gamble A, Williamson B, Lloyd-Smith JO. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. New England Journal of Medicine. 2020. DOI: 10.1101/2020.03.09.20033217
- Draft Operational planning guidelines to support country preparedness and response.
https://www.who.int/docs/default–source/coronaviruse/covid–19–sprp–unct–guidelines.pdf (accessed 30 April 2020). - Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the Covid-19 epidemic? The Lancet. 2020; 395(10228): 931–4. DOI: 10.1016/S0140-6736(20)30567-5
- Fuk-Woo CJ, Shuofeng Y, Kin-Hang K-K, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet. 2020; 395: 514–23. DOI: 10.1016/S0140-6736(20)30154-9
- Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: Challenges for global health governance. Jama. 2020; 323(8): 709–10. DOI: 10.1001/jama.2020.1097
- Nishiura H, Jung S–m, Linton NM, Kinoshita R, Yang Y, Hayashi K, et al.
The extent of transmission of novel coronavirus in Wuhan, China, 2020 . Multidisciplinary Digital Publishing Institute; 2020. DOI: 10.3390/jcm9020330 - Jin X, Lian JS, Hu JH, Gao J, Zheng L, Zhang YM, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus–infected disease 2019 (Covid-19) with gastrointestinal symptoms. Gut. 2020. DOI: 10.1136/gutjnl-2020-320926
- Ghebreyesus TA.
WHO Director–General’s opening remarks at the media briefing on Covid-19 11 March 2020 . World Health Organization.https://www-who-int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020 2020. - Global surveillance for human infection with novel coronavirus
(2019-nCoV): Interim guidance . Geneva, Switzerland: World Health Organization (WHO). (accessed 2020). - Coronavirus disease 2019 (Covid-19) Situation Report. Geneva: World Health Organization; 2020.
- Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with Covid-19 in Wuhan, China. JAMA Cardiology. 2020. DOI: 10.1001/jamacardio.2020.0950
- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020; 323(11): 1061–9. DOI: 10.1001/jama.2020.1585
- Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. European Heart Journal. 2020. DOI: 10.1093/eurheartj/ehaa190
- Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. Journal of Virology. 2020; 94(7). DOI: 10.1128/JVI.00127-20
- Jia HP, Look DC, Shi L, Hickey M, Pewe L, Netland J, et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. Journal of Virology. 2005; 79(23): 14614–21. DOI: 10.1128/JVI.79.23.14614-14621.2005
- Xiong T-Y, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: Acute and long-term implications. European Heart Journal. 2020. DOI: 10.1093/eurheartj/ehaa231
- Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on Covid-19 in China. Clinical Research in Cardiology. 2020: 1–8. DOI: 10.1007/s00392-020-01626-9
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with Covid-19 in Wuhan, China: A retrospective cohort study. The Lancet. 2020. DOI: 10.1016/S0140-6736(20)30566-3
- Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of Covid-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine. 2020; 8(4): 420–2. DOI: 10.1016/S2213-2600(20)30076-X
- Guan W-j, Ni Z-y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine. 2020. DOI: 10.1101/2020.02.06.20020974
- Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to Covid-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Medicine. 2020: 1–3. DOI: 10.1007/s00134-020-05991-x
- Wu C, Chen X, Cai Y, Zhou X, Xu S, Huang H, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Internal Medicine. 2020. DOI: 10.1001/jamainternmed.2020.0994
- Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020. DOI: 10.1016/S2213-2600(20)30079-5
- Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003; 348(20): 1986–94. DOI: 10.1056/NEJMoa030685.
- Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003; 289(21): 2801–9. DOI: 10.1001/jama.289.21.JOC30885.
- Li SS-l, Cheng C-w, Fu C-l, Chan Y-H, Lee M-P, Chan JW-M, et al. Left ventricular performance in patients with severe acute respiratory syndrome: A 30-day echocardiographic follow-up study. Circulation. 2003; 108(15): 1798–803. DOI: 10.1161/01.CIR.0000094737.21775.32
- Yu C, Wong RS, Wu E, Kong S, Wong J, Yip GW, et al. Cardiovascular complications of severe acute respiratory syndrome. Postgraduate Medical Journal. 2006; 82(964): 140–4. DOI: 10.1136/pgmj.2005.037515
- Saad M, Omrani AS, Baig K, Bahloul A, Elzein F, Matin MA, et al. Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: A single-center experience in Saudi Arabia. International Journal of Infectious Diseases. 2014; 29: 301–6. DOI: 10.1016/j.ijid.2014.09.003
- Al-Tawfiq JA, Hinedi K, Ghandour J, Khairalla H, Musleh S, Ujayli A, et al. Middle East respiratory syndrome coronavirus: A case-control study of hospitalized patients. Clinical Infectious Diseases. 2014; 59(2): 160–5. DOI: 10.1093/cid/ciu226
- Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: A descriptive study. The Lancet Infectious Diseases. 2013; 13(9): 752–61. DOI: 10.1016/S1473-3099(13)70204-4
- Schoen K, Horvat N, Guerreiro NF, de Castro I, de Giassi KS. Spectrum of clinical and radiographic findings in patients with diagnosis of H1N1 and correlation with clinical severity. BMC Infectious Diseases. 2019; 19(1): 1–8. DOI: 10.1186/s12879-019-4592-0
- Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395(10223): 497–506. DOI: 10.1016/S0140-6736(20)30183-5
- Guo T, Fan Y, Chen M. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (Covid-19). JAMA Cardiol. 2020. [e–pub ahead of print]. DOI: 10.1001/jamacardio.2020.1017
- Sellers SA, Hagan RS, Hayden FG, Fischer WA. The hidden burden of influenza: A review of the extra-pulmonary complications of influenza infection. Influenza and Other Respiratory Viruses. 2017; 11(5): 372–93. DOI: 10.1111/irv.12470
- Alexander LK, Small JD, Edwards S, Baric RS. An experimental model for dilated cardiomyopathy after rabbit coronavirus infection. Journal of Infectious Diseases. 1992; 166(5): 978–85. DOI: 10.1093/infdis/166.5.978
- Lau S-T, Yu W-C, Mok N-S, Tsui P-T, Tong W-L, Stella W. Tachycardia amongst subjects recovering from severe acute respiratory syndrome (SARS). International Journal of Cardiology. 2005; 100(1): 167–9. DOI: 10.1016/j.ijcard.2004.06.022
- Gastanaduy PA. Update: Severe respiratory illness associated with Middle East respiratory syndrome coronavirus (MERS–CoV)—worldwide, 2012–2013. MMWR Morbidity and Mortality Weekly Report. 2013; 62(23): 480.
- Maslow JN. Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus. Human Vaccines & Immunotherapeutics. 2017; 13(12): 2918–30. DOI: 10.1080/21645515.2017.1358325
- Nguyen JL, Yang W, Ito K, Matte TD, Shaman J, Kinney PL. Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiology. 2016; 1(3): 274–81. DOI: 10.1001/jamacardio.2016.0433
- Madjid M, Connolly AT, Nabutovsky Y, Safavi–Naeini P, Razavi M, Miller CC. Effect of high influenza activity on risk of ventricular arrhythmias requiring therapy in patients with implantable cardiac defibrillators and cardiac resynchronization therapy defibrillators. The American Journal of Cardiology. 2019; 124(1): 44–50. DOI: 10.1016/j.amjcard.2019.04.011
- Ang LW, Yap J, Lee V, Chng WQ, Jaufeerally FR, Lam CSP, et al. Influenza–associated hospitalizations for cardiovascular diseases in the tropics. American Journal of Epidemiology. 2017; 186(2): 202–9. DOI: 10.1093/aje/kwx001
- Stewart S, Keates AK, Redfern A, McMurray JJ. Seasonal variations in cardiovascular disease. Nature Reviews Cardiology. 2017; 14(11): 654. DOI: 10.1038/nrcardio.2017.76
- Modin D, Jørgensen ME, Gislason G, Jensen JS, Køber L, Claggett B, et al. Influenza vaccine in heart failure: Cumulative number of vaccinations, frequency, timing, and survival: A Danish nationwide cohort study. Circulation. 2019; 139(5): 575–86. DOI: 10.1161/CIRCULATIONAHA.118.036788
- Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (Covid-19). JAMA Cardiology. 2020. DOI: 10.1001/jamacardio.2020.1017
- Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (Covid-19). JAMA Cardiology. 2020; DOI: 10.1001/jamacardio.2020.1017.
- Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (Covid-19). JAMA Cardiology. 2020. DOI: 10.1001/jamacardio.2020.1096
- Langenbach MC, Hokamp NG, Persigehl T, Bratke G. MRI appearance of Covid-19 infection. Diagn Interv Radiol. 2020; 26(4): 377–8. DOI: 10.5152/dir.2020.20152.
- Zheng Y-Y, Ma Y-T, Zhang J-Y, Xie X. Covid-19 and the cardiovascular system. Nature Reviews Cardiology. 2020; 17(5): 259–60. DOI: 10.1038/s41569-020-0360-5
- Oudit G, Kassiri Z, Jiang C, Liu P, Poutanen S, Penninger J, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. European Journal of Clinical Investigation. 2009; 39(7): 618–25. DOI: 10.1111/j.1365-2362.2009.02153.x
- Yang C, Jin Z. An acute respiratory infection runs into the most common noncommunicable epidemic—Covid-19 and cardiovascular diseases. JAMA Cardiology. 2020. DOI: 10.1001/jamacardio.2020.0934
- Aryal MR, Gosain R, Donato A, Pathak R, Bhatt VR, Katel A, et al. Venous thromboembolism in Covid-19: Towards an ideal approach to thromboprophylaxis, screening, and treatment. Curr Cardiol Rep. 2020; 22(7): 52. DOI: 10.1007/s11886-020-01327-9
- Rokas S, Mavrikakis M, Ilipoulou A, Moulopoulos S. Electrophysiologic studies of the heart in patients with rheumatoid arthritis. International Journal of Cardiology. 1990; 26(1): 75–82. DOI: 10.1016/0167-5273(90)90250-9
- Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, et al. Observational study of hydroxychloroquine in hospitalized patients with Covid-19. New England Journal of Medicine. 2020. DOI: 10.1056/NEJMoa2012410
- Ratliff N, Estes M, McMahon J, Myles J. Chloroquine–induced cardiomyopathy. Archives of Pathology & Laboratory Medicine. 1988; 112(6): 578.
- Harris L, Downar E, Shaikh N, Chen T. Antiarrhythmic potential of chloroquine: New use for an old drug. The Canadian Journal of Cardiology. 1988; 4(6): 295–300.
- Chen C-Y, Wang F-L, Lin C-C. Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia. Clinical Toxicology. 2006; 44(2): 173–5. DOI: 10.1080/15563650500514558
- O’Laughlin JP, Mehta PH, Wong BC. Life threatening severe QTc prolongation in patient with systemic lupus erythematosus due to hydroxychloroquine. Case Reports in Cardiology. 2016; 2016. DOI: 10.1155/2016/4626279
- Frosch AE, Venkatesan M, Laufer MK. Patterns of chloroquine use and resistance in sub–Saharan Africa: A systematic review of household survey and molecular data. Malaria Journal. 2011; 10(1): 116. DOI: 10.1186/1475-2875-10-116
- Bloland P, Kazembe P, Oloo A, Himonga B, Barat L, Ruebush T. Chloroquine in Africa: Critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa. Tropical Medicine & International Health. 1998; 3(7): 543–52. DOI: 10.1046/j.1365-3156.1998.00270.x
- Ogah OS, Rayner BL. Recent advances in hypertension in sub–Saharan Africa. Heart. 2013; 99(19): 1390–7. DOI: 10.1136/heartjnl-2012-303227
- Glesby MJ, Aberg JA, Kendall MA, Fichtenbaum CJ, Hafner R, Hall S, et al. Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers. Clinical Pharmacology & Therapeutics. 2005; 78(2): 143–53. DOI: 10.1016/j.clpt.2005.04.005
- Lai AL, Millet JK, Daniel S, Freed JH, Whittaker GR. The SARS-CoV fusion peptide forms an extended bipartite fusion platform that perturbs membrane order in a calcium-dependent manner. Journal of Molecular Biology. 2017; 429(24): 3875–92. DOI: 10.1016/j.jmb.2017.10.017
- Straus MR, Bidon M, Tang T, Whittaker G, Daniel S. FDA approved calcium channel blockers inhibit SARS-CoV-2 infectivity in epithelial lung cells. bioRxiv. 2020. DOI: 10.1101/2020.07.21.214577
- Johnson RM, Vinetz JM. Dexamethasone in the management of Covid-19. British Medical Journal Publishing Group. 2020. DOI: 10.1136/bmj.m2648
- Group RC. Dexamethasone in hospitalized patients with Covid–19—Preliminary report. New England Journal of Medicine. 2020.
- Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in hospitalized patients with Covid–19—Preliminary report. The New England Journal of Medicine. 2020. DOI: 10.1101/2020.06.22.20137273
- Buchman AL. Side effects of corticosteroid therapy. Journal of Clinical Gastroenterology. 2001; 33(4): 289–94. DOI: 10.1097/00004836-200110000-00006
- Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, et al. Altered lipid metabolism in recovered sars patients twelve years after infection. Scientific Reports. 2017; 7(1): 1–12. DOI: 10.1038/s41598-017-09536-z
- Thienemann F, Dzudie A, Mocumbi AO, Blauwet L, Sani MU, Karaye KM, et al. The causes, treatment, and outcome of pulmonary hypertension in Africa: Insights from the Pan African Pulmonary Hypertension Cohort (PAPUCO) registry. International Journal of Cardiology. 2016; 221: 205–11. DOI: 10.1016/j.ijcard.2016.06.242
- Stewart S, Mocumbi AO, Carrington MJ, Pretorius S, Burton R, Sliwa K. A not-so-rare form of heart failure in urban black Africans: Pathways to right heart failure in the Heart of Soweto Study cohort. European Journal of Heart Failure. 2011; 13(10): 1070–7. DOI: 10.1093/eurjhf/hfr108
- Armah FA, Ekumah B, Yawson DO, Odoi JO, Afitiri A-R, Nyieku FE. Access to improved water and sanitation in sub–Saharan Africa in a quarter century. Heliyon. 2018; 4(11):
e00931 . DOI: 10.1016/j.heliyon.2018.e00931 - Organization WH.
Public financing for health in Africa: From Abuja to the SDGs . World Health Organization; 2016. - Reeves A, Gourtsoyannis Y, Basu S, McCoy D, McKee M, Stuckler D. Financing universal health coverage—Effects of alternative tax structures on public health systems: Cross-national modelling in 89 low-income and middle-income countries. The Lancet. 2015; 386(9990): 274–80. DOI: 10.1016/S0140-6736(15)60574-8
- Otu A, Ebenso B, Labonte R, Yaya S. Tackling Covid-19: Can the African continent play the long game?
- Lancet T. India under Covid-19 lockdown. Lancet (London, England). 2020; 395(10233): 1315. DOI: 10.1016/S0140-6736(20)30938-7
- Jewell BL, Mudimu E, Stover J, Ten Brink D, Phillips AN, Smith JA, et al. Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by Covid-19: Results from multiple mathematical models. Lancet HIV. 2020; 7(9): e629–e40. DOI: 10.1016/S2352-3018(20)30211-3
- Hogan AB, Jewell BL, Sherrard–Smith E, Vesga JF, Watson OJ, Whittaker C, et al. Potential impact of the Covid-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: A modelling study. Lancet Glob Health. 2020; 8(9): e1132–e41. DOI: 10.1016/S2214-109X(20)30288-6.
- Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al–Jabir A, Iosifidis C, et al. The Socio-economic implications of the coronavirus and Covid-19 pandemic: A review. International Journal of Surgery. 2020. DOI: 10.1016/j.ijsu.2020.04.018
- Impact of the Coronavirus Covid-19 on the African Economy.
https://au.int/sites/default/files/documents/38326-doc-covid-19_impact_on_african_economy.pdf (accessed 29 April 2020) - Organization WH.
Pandemic influenza preparedness and response: A WHO guidance document . Geneva: World Health Organization; 2009. - Pulla P.
Covid-19: India imposes lockdown for 21 days and cases rise . British Medical Journal Publishing Group; 2020. DOI: 10.1136/bmj.m1251 - Kapata N, Ihekweazu C, Ntoumi F, Raji T, Chanda-Kapata P, Mwaba P, et al. Is Africa prepared for tackling the Covid-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future. International Journal of Infectious Diseases. 2020; 93: 233–6. DOI: 10.1016/j.ijid.2020.02.049
- Chiang C, El Sony A. Tackling the threat of Covid-19 in Africa: An urgent need for practical planning. Int J Tuberc Lung Dis. 2020; 24. DOI: 10.5588/ijtld.20.0192
- Wang Z, Tang K. Combating Covid-19: health equity matters. Nature Medicine. 2020: 1. DOI: 10.1038/s41591-020-0823-6
- van Dorn A, Cooney RE, Sabin ML. Covid-19 exacerbating inequalities in the US. The Lancet. 2020; 395(10232): 1243–4. DOI: 10.1016/S0140-6736(20)30893-X
- Hamzelou J.
World in lockdown . Elsevier; 2020. DOI: 10.1016/S0262-4079(20)30611-4 - Ozili PK. Covid-19 in Africa: Socioeconomic impact, policy response and opportunities. Policy Response and Opportunities. 2020. DOI: 10.2139/ssrn.3574767
- Gilbert M, Pullano G, Pinotti F, Valdano E, Poletto C, Boëlle P–Y, et al. Preparedness and vulnerability of African countries against importations of Covid-19–19: A modelling study. The Lancet. 2020; 395(10227): 871–7. DOI: 10.1016/S0140-6736(20)30411-6
- Wright JE,
2nd , Merritt CC. Social Equity and Covid-19: The case of African Americans. Public Adm Rev. 2020. DOI: 10.1111/puar.13251. - Yancy CW. Covid-19 and African Americans. JAMA. 2020; 323(19): 1891–2. DOI: 10.1001/jama.2020.6548.
- Hamidian Jahromi A, Hamidianjahromi A. Why African Americans are a potential target for Covid-19 infection in the United States. J Med Internet Res. 2020; 22(6):
e19934 . DOI: 10.2196/19934 - Henry Akintobi T, Jacobs T, Sabbs D, Holden K, Braithwaite R, Johnson LN, et al. Community engagement of African Americans in the era of Covid-19: Considerations, challenges, implications, and recommendations for Public Health. Prev Chronic Dis. 2020; 17:
E83 . DOI: 10.5888/pcd17.200255. - Coughlin SS, Moore JX, George V, Johnson JA, Hobbs J. Covid-19 among African Americans: From preliminary epidemiological surveillance data to public health action. Am J Public Health. 2020; 110(8): 1157–9. DOI: 10.2105/AJPH.2020.305764.
- Strickland OL, Powell–Young Y, Reyes–Miranda C, Alzaghari O, Giger JN. African–Americans have a higher propensity for death from Covid-19: Rationale and causation. J Natl Black Nurses Assoc. 2020; 31(1): 1–12.
- McGonagle D, Plein S, O’Donnell JS, Sharif K, Bridgewood C. Increased cardiovascular mortality in African Americans with Covid-19. Lancet Respir Med. 2020; 8(7): 649–51: DOI: 10.1016/S2213-2600(20)30244-7.
- Chitungo I, Dzobo M, Hlongwa M, Dzinamarira T. Covid-19: Unpacking the low number of cases in Africa. Public Health in Practice. 2020; 1: 100038. DOI: 10.1016/j.puhip.2020.100038
- Lawal Y. Africa’s low Covid-19 mortality rate: A paradox? International Journal of Infectious Diseases. 2020; 102: 118–22. DOI: 10.1016/j.ijid.2020.10.038
- Zeberg H, Pääbo S. The major genetic risk factor for severe Covid-19 is inherited from Neanderthals. Nature. 2020: 1–3. DOI: 10.1101/2020.07.03.186296
- Al-Abdallat MM, Payne DC, Alqasrawi S, Rha B, Tohme RA, Abedi GR, et al. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: A serologic, epidemiologic, and clinical description. Clinical Infectious Diseases. 2014; 59(9): 1225–33. DOI: 10.1093/cid/ciu359
DOI: https://doi.org/10.5334/gh.829 | Journal eISSN: 2211-8179
Language: English
Submitted on: May 26, 2020
Accepted on: Jan 13, 2021
Published on: Mar 15, 2021
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2021 Okechukwu S. Ogah, Ejiroghene M. Umuerri, Adewole Adebiyi, Olanike A. Orimolade, Mahmoud U. Sani, Dike B. Ojji, Amam C. Mbakwem, Simon Stewart, Karen Sliwa, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.